[1] AKBOGA MK, CANPOLAT U, SAHINARSLAN A, et al. Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation[J]. Atherosclerosis, 2015, 240(1): 110. doi: 10.1016/j.atherosclerosis.2015.02.051
[2] SHAH P, BAJAJ S, VIRK H, et al. Rapid progression of coronary atherosclerosis: a review[J]. Thrombosis, 2015, 2015(2): 1.
[3] MACDONALD SPJ, BOSIO E, NEIL C, et al. Resistin and NGAL are associated with inflammatory response, endothelial activation and clinical outcomes in sepsis[J]. Inflamm Res, 2017, 66(7): 611. doi: 10.1007/s00011-017-1043-5
[4] RAJAPPA M, GOSWAMI B, BALASUBRAMANIAN A, et al. Interplay between inflammation and hemostasis in patients with coronary artery disease[J]. Indian J Clin Biochem, 2015, 30(3): 281. doi: 10.1007/s12291-014-0438-0
[5] ZHUANG Q, SHEN C, CHEN Y, et al. Association of high sensitive C-reactive protein with coronary heart disease: a mendelian randomization study[J]. BMC Med Genet, 2019, 20(1): 170. doi: 10.1186/s12881-019-0910-z
[6] TAYEFI M, TAJFARD M, SAFFAR S, et al. Hs-CRP is strongly associated with coronary heart disease(CHD): a data mining approach using decision tree algorithm[J]. Comput Meth Prog Bio, 2017, 141(3): 105.
[7] SOYLU K, NAR G, AKSAN G, et al. Serum neutrophil gelatinase-associated lipocalin levels and aortic stiffness in noncritical coronary artery disease[J]. Cardiorenal Med, 2014, 4(3/4): 147.
[8] SAVIC-RADOJEVIC A, PLJESA-ERCEGOVAC M, MATIC M, et al. Novel biomarkers of heart failure[J]. Adv Clin Chem, 2016, 79(5): 93.
[9] LI C, ZHANG Z, PENG Y, et al. Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease[J]. PLoS One, 2019, 14(8): e0220841. doi: 10.1371/journal.pone.0220841
[10] MA CY, XU ZY, WANG SP, et al. Change of inflammatory factors in patients with acute coronary syndrome[J]. Chinese Med J, 2018, 131(12): 1444. doi: 10.4103/0366-6999.233953
[11] KARADENIZ M, DURAN M, AKYEL A, et al. High sensitive CRP level is associated with intermediate and high syntax score in patients with acute coronary syndrome[J]. Int Heart J, 2015, 56(4): 377. doi: 10.1536/ihj.14-299
[12] YAGHOUBI A, GHOJAZADEH M, ABOLHASANI S, et al. Correlation of serum levels of vitronectin, malondialdehyde and hs-CRP with disease severity in coronary artery disease[J]. J Cardiovasc Thorac Res, 2015, 7(3): 113. doi: 10.15171/jcvtr.2015.24
[13] AKCAY AB, OZLU MF, SENEN N, et al. Prognostic significance of neutrophil gelatinase-associated lipocalin in ST-segment elevation myocardial infarction[J]. J Investig Med, 2012, 60(2): 508. doi: 10.2310/JIM.0b013e31823e9d86
[14] KATAGIRI M, TAKAHASHI M, DOIK, et al. Serum neutrophil gelatinase-associated lipocalin concentration reflects severity of coronary artery disease in patients without heart failure and chronic kidney disease[J]. Heart Vessels, 2015, 31(10): 1.
[15] YNDESTAD A, LANDRO L, UELAND T, et al. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin inclinical and experimental heart failure[J]. Eur Heart J, 2009, 30(10): 1229. doi: 10.1093/eurheartj/ehp088
[16] BIELECKA-DABROWA A, GLUBA-BRZOZKA A, MICHALSKA-KASICZAK M, et al. The multi-biomarker approach for heart failure in patients with hypertension[J]. Int J Mol Sci, 2015, 16(5): 10715.
[17] 马续祥, 陈卫东, 纵晓英, 等. 血清NGAL在早期2型糖尿病肾脏疾病诊断中的作用[J]. 蚌埠医学院学报, 2018, 43(5): 595.
[18] HEMDAHL AL, GABRIELSEN A, ZHU C, et al. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction[J]. Arterioscler Thromb Vasc Biol, 2006, 26(1): 136. doi: 10.1161/01.ATV.0000193567.88685.f4